Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 18/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.74 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.74 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.68 |
| ▸ | MPO | P05164 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3961213 | 1.00 | GRIK1 (1.00) | GRIK1MEN1KMT2ANTRK1CDK19 | |
| SCHEMBL5464394 | 0.90 | GRIK1 (0.82) | GRIK1MEN1KMT2ANTRK1CDK19 | |
| SCHEMBL1463123 | 0.90 | GRIK1 (1.00) | GRIK1MEN1KMT2ANTRK1CDK19 | |
| SCHEMBL1463260 | 0.89 | GRIK1 (0.81) | GRIK1MEN1KMT2A | |
| SCHEMBL6430905 | 0.86 | GRIK1 (1.00) | GRIK1MEN1KMT2AGRIK2 | |
| SCHEMBL10385394 | 0.86 | MPO (0.81) | GRIK1MEN1KMT2ANTRK1CDK19 | |
| SCHEMBL5597796 | 0.86 | NTRK1 (0.79) | GRIK1MEN1KMT2ANTRK1CDK19 | |
| SCHEMBL29835007 | 0.86 | MPO (0.81) | GRIK1MEN1KMT2ANTRK1CDK19 | |
| SCHEMBL3961840 | 0.86 | GRIK1 (1.00) | GRIK1MEN1KMT2AGRIK2 | |
| SCHEMBL6435235 | 0.85 | GRIK1 (1.00) | GRIK1MEN1KMT2ANTRK1CDK19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313007-A1 | TRANSDERMAL SYSTEM, FORMULATION, AND METHOD FOR THE THERAPEUTIC ADMINISTRATION OF A PSYCHEDELIC AGENT | Lyfe CHNG, LLC (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022221072-A1 | TRANSDERMAL SYSTEM, FORMULATION, AND METHOD FOR THE THERAPEUTIC ADMINISTRATION OF A PSYCHEDELIC AGENT | MYCRODOSE THERAPEUTICS INC. (US) | 2022-10-20 | — | — | WO | disclosed |
| WO-2022212789-A1 | TRANSDERMAL SYSTEM, FORMULATION, AND METHOD FOR THE THERAPEUTIC ADMINISTRATION OF A PSYCHEDELIC AGENT | MYCRODOSE THERAPEUTICS INC. (US) | 2022-10-06 | — | — | WO | disclosed |